Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Y Choi

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Thrombosis and Haemostasis : JTH|May 21, 2022
SkM-ing information from traumatized tissuePhilip J Crispin, Philip Y Choi, Elizabeth E Gardiner
European Journal of Radiology|December 29, 2020
R2 and R2* MRI assessment of liver iron content in an undifferentiated diagnostic population with hyperferritinaemia, and impact on clinical decision makingMelissa L Craft, Morgan Edwards, Tarun Pankaj Jain, et al.
Platelets|February 15, 2020
Novel scientific approaches and future research directions in understanding ITPSarah M Hicks, Lucy A Coupland, Anila Jahangiri, et al.
Clinical Science (London, England : 1979)|November 3, 2020
The molecular basis of immune-based platelet disordersSarah M Hicks, Christine S M Lee, Sidra A Ali, et al.
Journal of Thrombosis and Haemostasis : JTH|June 2, 2021
The SSC platelet immunology register of VITT and VIITP: Toward standardization of laboratory and clinical parametersPhilip Y Choi, Rachael F Grace, Maria Therese Ahlen, et al.
Asia-Pacific Journal of Clinical Oncology|January 15, 2024
Response to COVID-19 vaccination in patients on cancer therapy: Analysis in a SARS-CoV-2-naïve populationGeorge Cavic, Andrew A Almonte, Sarah M Hicks, et al.
Blood Advances|February 22, 2024
Long-term treatment with rilzabrutinib in patients with immune thrombocytopeniaDavid J Kuter, Jiri Mayer, Merlin Efraim, et al.
The New England Journal of Medicine|April 13, 2022
Rilzabrutinib, an Oral BTK Inhibitor, in Immune ThrombocytopeniaDavid J Kuter, Merlin Efraim, Jiri Mayer, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Thrombosis and Haemostasis : JTH|May 21, 2022
SkM-ing information from traumatized tissuePhilip J Crispin, Philip Y Choi, Elizabeth E Gardiner
European Journal of Radiology|December 29, 2020
R2 and R2* MRI assessment of liver iron content in an undifferentiated diagnostic population with hyperferritinaemia, and impact on clinical decision makingMelissa L Craft, Morgan Edwards, Tarun Pankaj Jain, et al.
Platelets|February 15, 2020
Novel scientific approaches and future research directions in understanding ITPSarah M Hicks, Lucy A Coupland, Anila Jahangiri, et al.
Clinical Science (London, England : 1979)|November 3, 2020
The molecular basis of immune-based platelet disordersSarah M Hicks, Christine S M Lee, Sidra A Ali, et al.
Journal of Thrombosis and Haemostasis : JTH|June 2, 2021
The SSC platelet immunology register of VITT and VIITP: Toward standardization of laboratory and clinical parametersPhilip Y Choi, Rachael F Grace, Maria Therese Ahlen, et al.
Asia-Pacific Journal of Clinical Oncology|January 15, 2024
Response to COVID-19 vaccination in patients on cancer therapy: Analysis in a SARS-CoV-2-naïve populationGeorge Cavic, Andrew A Almonte, Sarah M Hicks, et al.
Blood Advances|February 22, 2024
Long-term treatment with rilzabrutinib in patients with immune thrombocytopeniaDavid J Kuter, Jiri Mayer, Merlin Efraim, et al.
The New England Journal of Medicine|April 13, 2022
Rilzabrutinib, an Oral BTK Inhibitor, in Immune ThrombocytopeniaDavid J Kuter, Merlin Efraim, Jiri Mayer, et al.
Pageof 1